Erick Lucera
CIK 1697616 · Chief Financial Officer · last filed 2026-05-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.55M
Companies
7
Total Filings
36
Lifetime Open-Market Net
-$199.1K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DYN | Chief Financial Officer | 123,925 | $18.19 | $2.25M | -$133.3K | 4 | 2026-05-14 |
| SABSW | Director | — | $0.01 | — | $0 | 3 | 2025-12-18 |
| XAIR | Director | 43,608 | $0.37 | $16.2K | $29.2K | 10 | 2025-11-06 |
| EDIT | EVP, CHIEF FINANCIAL OFFICER | 112,720 | $2.50 | $281.8K | -$132.4K | 5 | 2025-03-27 |
| BBLGW | Director | — | $15.34 | — | $0 | 3 | 2023-09-20 |
| AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Chief Financial Officer | — | $15.00 | — | $0 | 4 | 2023-01-19 |
| Valeritas Holdings Inc. (VLRX) Delisted | See Remarks | 4,500 | — | — | $37.4K | 5 | 2019-03-08 |
Recent Filings · Page 2 of 4
36 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-08-15 | XAIR | Buy (P) | +39,266 | $15.6K | EDGAR |
| 2024-07-17 | SABSW | Grant (A) | — | $0 | EDGAR |
| 2024-05-22 | EDIT | Sell (S) | −22,337 | -$125.4K | EDGAR |
| 2024-03-21 | XAIR | Grant (A) | — | $0 | EDGAR |
| 2024-03-05 | EDIT | Grant (A) | +61,266 | $0 | EDGAR |
| 2023-09-20 | BBLGW | Grant (A) | — | $0 | EDGAR |
| 2023-05-18 | EDIT | Grant (A) | +77,900 | $0 | EDGAR |
| 2023-04-05 | SABSW | Grant (A) | — | $0 | EDGAR |
| 2023-03-31 | XAIR | Grant (A) | — | $0 | EDGAR |
| 2023-03-20 | XAIR | Buy (P) | +2,000 | $13.6K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.